TRIPS Waiver Proposal: State of Play and the Way Forward

Introduction

0001A panel discussion on “TRIPS Waiver Proposal – State of Play and the Way Forward” was organised on 18 December 2020 by Chinmaya Vishwavidyapeeth, in collaboration with National Law University Delhi (NLUD), the Inter-University Centre for IPR Studies (IUCIPRS), Cochin University of Science and Technology (CUSAT), and the Third World Network (TWN). The discussion was organised under the aegis of the 4th International Conference on New Frontiers in Sanskrit and Indic Knowledge (NFSI), themed “Law, Public Policy and Governance.”

0002The panel sought to examine the proposed waiver of certain obligations under the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS) in the context of the COVID-19 pandemic. It provided a platform to deliberate on the relationship between intellectual property protection, innovation, public health, and equitable access to medicines, vaccines, and other medical technologies.

Background and Context

0003The COVID-19 pandemic brought renewed attention to the challenges of ensuring timely and affordable access to essential medical products across the world. While intellectual property rights play an important role in encouraging research and innovation, questions arose regarding whether the existing international intellectual property framework could adequately address the urgent public health needs of countries, particularly developing nations.

0004In response to these concerns, India and South Africa, with the support of other developing countries, proposed a temporary waiver of certain TRIPS obligations at the World Trade Organization (WTO). The proposal aimed to facilitate the development, production, and availability of COVID-19-related medical products by providing greater flexibility in the application of intellectual property protections during the pandemic.

0005The proposal generated considerable international debate, receiving support from several WTO members, international organisations, academics, and civil society groups, while some developed countries expressed reservations. Against this backdrop, the panel discussion sought to examine the status of the proposal, the issues surrounding its consideration at the WTO, and its broader implications for public health and international intellectual property policy.

Panellists and Moderator

0006The discussion featured the following distinguished speakers:

0007Prof. (Dr.) Biswajith Dhar, Centre for Economic Studies and Planning, School of Social Sciences, Jawaharlal Nehru University (JNU), and former Member of the Board of Trade.

0008Shri Mustaqeem de Gama, Counsellor, South African Mission to the WTO.

0009Dr. Hu Yuan Qiong, PhD, Policy Co-coordinator and Senior Legal and Policy Advisor, Médecins Sans Frontières (MSF) Access Campaign.

0010The session was moderated by Mr. K. M. Gopakumar, Legal Advisor and Senior Researcher at the Third World Network.

0011Prof. Yogesh Pai, Assistant Professor of Law at National Law University Delhi and Associate Rapporteur, NFSI, delivered the opening remarks.

Key Themes of the Discussion

0012The panel focused on the significance of the proposed TRIPS waiver in responding to the public health challenges posed by COVID-19. The central themes included:

0013Intellectual property and access to medicines: The discussion examined the relationship between intellectual property protection and the availability and affordability of essential medicines and medical technologies during a global health emergency.

0014The proposed TRIPS waiver: The panel considered the rationale behind the waiver proposal, its objectives, and the importance of international cooperation in addressing barriers to the production and distribution of COVID-19-related medical products.

0015Developing countries and public health priorities: The discussion highlighted the concerns of developing countries regarding access to healthcare technologies and the need for an international framework that responds effectively to public health emergencies.

0016The role of the WTO and international cooperation: The proposal's consideration within the WTO framework underscored the importance of multilateral dialogue, policy coordination, and collaboration among member countries and international organisations.

0017Innovation, intellectual property, and public interest: The panel addressed the broader policy challenge of balancing incentives for innovation with the need to ensure equitable access to life-saving technologies, particularly during a pandemic.

Conclusion

0018The panel discussion on “TRIPS Waiver Proposal – State of Play and the Way Forward” addressed an important and timely question at the intersection of intellectual property law, international trade, and public health. By bringing together perspectives from academia, international policy, and public health advocacy, the event provided a platform to examine the implications of the proposed waiver and the challenges of ensuring equitable access to COVID-19-related medical technologies.

0019The discussion formed part of the broader objectives of the 4th International Conference on New Frontiers in Sanskrit and Indic Knowledge, which explored contemporary legal and public policy issues through interdisciplinary perspectives. It also reflected the importance of continued dialogue on intellectual property governance and its role in promoting innovation while responding to pressing public interest concerns.